Substance (Drug) Abuse - Epidemiology Insights to 2025

Publisher Name :
Date: 28-Jul-2017
No. of pages: 40
Price : Single User: US $ 2950  US $ 2360 Corporate User: US $ 8850  US $ 5310
This report is available at 20% Discount for Single User License and 40% Discount for Corporate Users License till 31 December 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Substance (Drug) Abuse -Epidemiology Forecast, 2025" provides an overview of the epidemiology trends of Substance (Drug) Abuse in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Substance (Drug) Abuse. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical needs associated with the Substance (Drug) Abuse. The report contains the targeted patient populations and the forecast methodology.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by DelveInsight team of industry experts.

Key Coverage and Benefits

  • The Report includes the prevalent population and how will it change over the next eight years.

  • Coverage of key Substance (Drug) Abuse sub-populations and its prevalent or incident cases

  • Prevalent or incident cases segmented by age and sex.

  • The key differences in epidemiology patterns across the seven market segments.

Reasons to buy

  • Developing business strategies by understanding the trends shaping and driving the global Substance (Drug) Abuse market.

  • Identifying prevalent patient populations as well as risk factors in the global Substance (Drug) Abuse market will help to improve product design, pricing, and launch plans.

  • Organize sales and marketing efforts by identifying the best opportunities for Substance (Drug) Abuse therapeutics in each of the markets covered.

This report is available at 20% Discount for Single User License and 40% Discount for Corporate Users License till 31 December 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

Substance (Drug) Abuse - Epidemiology Insights to 2025

Table of Contents

1. Report Introduction

2. Snapshot of Total Prevalent or Incident cases by 7 MM

3. Executive Summary
Key Findings

4. Substance (Drug) Abuse Overview
Substance (Drug) Abuse Definition
Pathophysiology
Symptoms
Etiology

5. Risk Factors Associated with Substance (Drug) Abuse

6. Disease Burden & Unmet Need in the Market

7. Epidemiology and Patient Populations
Key Findings
Key Sources used and Forecast Methodology
Prevalent Cases and Incident Cases-2015-2025
Prevalent & Incident Cases by Category-2015-2025
Age-Specific Prevalent/ Incident Cases of Substance (Drug) Abuse
Sex-Specific Prevalent/Incident Cases of Substance (Drug) Abuse
Disease Type Specific Prevalent/Incident Cases of Substance (Drug) Abuse

8.Prevalent & Incident Cases by 7 MM-2015-2025
Substance (Drug) Abuse Epidemiology of United States-2025
Substance (Drug) Abuse Epidemiology of United Kingdom-2025
Substance (Drug) Abuse Epidemiology of Germany-2025
Substance (Drug) Abuse Epidemiology of France-2025
Substance (Drug) Abuse Epidemiology of Spain-2025
Substance (Drug) Abuse Epidemiology of Italy-2025
Substance (Drug) Abuse Epidemiology of Japan-2025

9. Key Takeaways

10. Appendix

11.Report Methodology

12. Consulting Services

13. Disclaimer

14. About Us

List of Tables

Table 1: Clinical subtypes of Indication
Table 2: Risk Factors
Table 3: Prevalence cases (%) Region wise
Table 4: Sources used for forecasting the data
Table 5: Substance (Drug) Abuse Global Epidemiology, (2015-2025)
Table 6: Prevalent Cases of Substance (Drug) Abuse (Ages =XX Years), US (2015-2025)
Table 7: Prevalent Cases of Substance (Drug) Abuse By Sex (Males & Females), US (2015-2025)
Table 8: Prevalent Cases By Substance (Drug) Abuse Sub-population, US (2015-2025)
Table 9: Prevalent Cases of Substance (Drug) Abuse (Ages =XX Years), United Kingdom (2015-2025)
Table 10: Prevalent Cases of Substance (Drug) Abuse By Sex (Males & Females), United Kingdom (2015-2025)
Table 11: Prevalent Cases By Substance (Drug) Abuse Sub-population, United Kingdom (2015-2025)
Table 12: Prevalent Cases of Substance (Drug) Abuse (Ages =XX Years), Germany (2015-2025)
Table 13: Prevalent Cases of Substance (Drug) Abuse By Sex (Males & Females), Germany (2015-2025)
Table 14: Prevalent Cases By Substance (Drug) Abuse Sub-population, Germany (2015-2025)
Table 15: Prevalent Cases of Substance (Drug) Abuse (Ages =XX Years), France (2015-2025)
Table 16: Prevalent Cases of Substance (Drug) Abuse By Sex (Males & Females), France (2015-2025)
Table 17: Prevalent Cases By Substance (Drug) Abuse Sub-population, France (2015-2025)
Table 18: Prevalent Cases of Substance (Drug) Abuse (Ages =XX Years), Italy (2015-2025)
Table 19: Prevalent Cases of Substance (Drug) Abuse By Sex (Males & Females), Italy (2015-2025)
Table 20: Prevalent Cases By Substance (Drug) Abuse Sub-population, Italy (2015-2025)
Table 21: Prevalent Cases of Substance (Drug) Abuse (Ages =XX Years), Spain (2015-2025)
Table 22: Prevalent Cases of Substance (Drug) Abuse By Sex (Males & Females), Spain (2015-2025)
Table 23: Prevalent Cases By Substance (Drug) Abuse Sub-population, Spain (2015-2025)
Table 24: Prevalent Cases of Substance (Drug) Abuse (Ages =XX Years), Japan (2015-2025)
Table 25: Prevalent Cases of Substance (Drug) Abuse By Sex (Males & Females), Japan (2015-2025)
Table 26: Prevalent Cases By Substance (Drug) Abuse Sub-population, Japan (2015-2025)

List of Figures

Figure 1: Prevalence cases (%) Region wise
Figure 2: Sources used for forecasting the data
Figure 3: Substance (Drug) Abuse Global Epidemiology, (2015-2025)
Figure 4: Prevalent Cases of Substance (Drug) Abuse (Ages =XX Years), US (2015-2025)
Figure 5: Prevalent Cases of Substance (Drug) Abuse By Sex (Males & Females), US (2015-2025)
Figure 6: Prevalent Cases By Substance (Drug) Abuse Sub-population,US (2015-2025)
Figure 7: Prevalent Cases of Substance (Drug) Abuse (Ages =XX Years), United Kingdom (2015-2025)
Figure 8: Prevalent Cases of Substance (Drug) Abuse By Sex (Males & Females), United Kingdom (2015-2025)
Figure 9: Prevalent Cases By Substance (Drug) Abuse Sub-population,United Kingdom (2015-2025)
Figure 10: Prevalent Cases of Substance (Drug) Abuse (Ages =XX Years), Germany (2015-2025)
Figure 11: Prevalent Cases of Substance (Drug) Abuse By Sex (Males & Females), Germany (2015-2025)
Figure 12: Prevalent Cases By Substance (Drug) Abuse Sub-population,Germany (2015-2025)
Figure 13: Prevalent Cases of Substance (Drug) Abuse (Ages =XX Years), France (2015-2025)
Figure 14: Prevalent Cases of Substance (Drug) Abuse By Sex (Males & Females), France (2015-2025)
Figure 15: Prevalent Cases By Substance (Drug) Abuse Sub-population,France (2015-2025)
Figure 16: Prevalent Cases of Substance (Drug) Abuse (Ages =XX Years), Italy (2015-2025)
Figure 17: Prevalent Cases of Substance (Drug) Abuse By Sex (Males & Females), Italy (2015-2025)
Figure 18: Prevalent Cases By Substance (Drug) Abuse Sub-population,Italy (2015-2025)
Figure 19: Prevalent Cases of Substance (Drug) Abuse (Ages =XX Years), Spain (2015-2025)
Figure 20: Prevalent Cases of Substance (Drug) Abuse By Sex (Males & Females), Spain (2015-2025)
Figure 21: Prevalent Cases By Substance (Drug) Abuse Sub-population,Spain (2015-2025)
Figure 22: Prevalent Cases of Substance (Drug) Abuse (Ages =XX Years), Japan (2015-2025)
Figure 23: Prevalent Cases of Substance (Drug) Abuse By Sex (Males & Females), Japan (2015-2025)
Figure 24: Prevalent Cases By Substance (Drug) Abuse Sub-population,Japan (2015-2025)
  • United States Lyme Disease Vaccine Market Report 2017
    Published: 13-Dec-2017        Price: US 3800 Onwards        Pages: 103
    In this report, the United States Lyme Disease Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rat......
  • Global Nociceptin Receptor Market Research Report 2017
    Published: 13-Dec-2017        Price: US 2900 Onwards        Pages: 100
    In this report, the global Nociceptin Receptor market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Nociceptin Receptor in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China......
  • Global Carglumic Acid Market Research Report 2017
    Published: 13-Dec-2017        Price: US 2900 Onwards        Pages: 107
    In this report, the global Carglumic Acid market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Carglumic Acid in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Japan......
  • Global Thin Film Drug Market Research Report 2017
    Published: 13-Dec-2017        Price: US 2900 Onwards        Pages: 118
    In this report, the global Thin Film Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Thin Film Drug in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Japan......
  • United States Inhalation & Nasal Spray Generic Drugs Market Report 2017
    Published: 12-Dec-2017        Price: US 3800 Onwards        Pages: 110
    In this report, the United States Inhalation & Nasal Spray Generic Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market sh......
  • North America Thin Film Drug Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 12-Dec-2017        Price: US 4480 Onwards        Pages: 121
    Thin-film drug delivery uses a dissolving film or oral drug strip to administer drugs via absorption in the mouth and/or via the small intestines. A film is prepared using hydrophilic polymers that rapidly dissolves on the tongue or buccal cavity, delivering the drug to the systemic circulation via dissolution when contact with liquid is made. Scope of the Report: This report focuses on the Thin Film Drug in North America market, especially in United States, Canada and Mexi......
  • Global Human Combination Vaccines Sales Market Report 2017
    Published: 12-Dec-2017        Price: US 4000 Onwards        Pages: 104
    In this report, the global Human Combination Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Human Combination Vaccines for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe......
  • Global Varicella Attenuated Live Vaccine Market Research Report 2017
    Published: 12-Dec-2017        Price: US 2900 Onwards        Pages: 109
    In this report, the global Varicella Attenuated Live Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Varicella Attenuated Live Vaccine in these regions, from 2012 to 2022 (forecast), covering - North America ......
  • Global Omnitrope Sales Market Report 2017
    Published: 12-Dec-2017        Price: US 4000 Onwards        Pages: 108
    In this report, the global Omnitrope market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Omnitrope for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japan - Southeast......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs